Physician profile
Jeffrey S Olson
NPI 1821403585
$1,702.18
in general payments reported to CMS, 2019-2025
22 companies · $59.75 in 2025
The $59.75 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $139 · 2021: $250 · 2022: $142 · 2024: $259 · 2025: $59.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $757.86 | 2019-2022 | |
| Abbvie INC. | $125.00 | 2024 | |
| Novo Nordisk INC | $113.91 | 2020-2021 | |
| Treace Medical Concepts, INC. | $103.16 | 2024-2025 | |
| Stryker Corporation | $84.64 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $66.47 | 2021-2022 | |
| Pfizer INC. | $66.15 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $64.58 | 2019-2021 | |
| Amgen INC. | $54.33 | 2019-2022 | |
| Prism Medical | $42.69 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.20 | 2020-2022 | |
| Smith+Nephew, INC. | $37.02 | 2021-2024 | Grafix Pl, Oasis, Stravix Pl |
| Medtronic USA, INC. | $24.78 | 2019 | |
| Ironwood Pharmaceuticals, INC | $19.05 | 2020 | |
| Mimedx Group, INC. | $15.21 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.77 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.05 | 2024 | Nuzyra |
| Amarin Pharma, INC. | $12.53 | 2021 | |
| Lilly USA, LLC | $12.19 | 2021 | |
| Arthrex, INC. | $12.08 | 2020 | |
| Eisai INC. | $11.90 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.